Optimize your vaccine purification workflow
We are committed to helping you accelerate the downstream purification of your vaccines. Explore our key considerations for implementing resins in various vaccine modalities, such as protein subunits, virus-like particles, and viral vectors.
Articles
Affinity Tags Head Toward the Vaccination Clinic (C-tag) Purification
Learn how the Jenner Institute uses affinity tags to streamline malaria vaccine development.
Get in the mRNA vaccine race
Learn how a novel affinity chromatograph resin contributes to fast, efficient, and scalable mRNA purification.
COVID-19 mRNA vaccine approvals: Key lessons for cell and gene therapy and mRNA therapeutic development
Read the conversation between thought-leaders from both the mRNA vaccine and therapeutics spheres as they share a unique cross-pollination of manufacturing experiences and ideas between both worlds.
Addressing Challenges Across the Virus-Like Particle Workflow
Read to understand how an integrated system of tools for protein expression, affinity purification, and quality control testing can help support efficient and cost-effective virus like particle production on a commercial scale.
How Affinity Tags Are Speeding Up Malaria Vaccine Development
Read to learn how the C-tag affinity tag system is applied as a standard purification process for candidate malaria vaccines to support efficient translation into clinical trials.
Purification and Quality Control Solutions to Accelerate Vaccine Development
Read to discover how novel chromatography solutions and analytical testing can help improve the downstream processes of different vaccine modalities such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).
eBooks
Managing Purity in Vaccines: How Advanced Purification Technologies are Speeding the Hunt for New Protections Against Disease
Explore recent developments in the purification of various vaccine modalities such as VLPs, mRNA, and protein subunits, through this collection of articles.
Intensify Vaccine Development with Innovative Purification Solutions
Gain more insights into various vaccine modalities and how they are efficiently purified through this collection of articles, webinars, and infographics.
Webinars
Enabling Rapid Vaccine Development through Manufacturing Innovation and Process Efficiency
Learn how to implement an efficient downstream purification process and avoid bottlenecks in the manufacturing of vaccines and new modalities.
Streamlining Vaccine Development and Production with Modality-specific Purification Tools for mRNA and Beyond
Expand your knowledge on purification tools used for rapid candidate screening and intensified downstream processing of vaccine modalities.
COVID-19 mRNA Vaccine Approvals: Key Lessons for Cell and Gene Therapy and mRNA Therapeutic Development
Watch a conversation between thought-leaders from both the mRNA vaccine and therapeutics spheres as they share a unique cross-pollination of manufacturing experiences and ideas between both worlds.
Improving and Intensifying Vaccine Purification by Implementing Affinity Chromatography
Understand how affinity chromatography can aid vaccine development and manufacturing by improving purification of vaccine modalities such as mRNA and protein subunits.
Virus-Like Particle Production in Insect Cells Using Baculovirus Express System: Addressing Challenges Across the Workflow
Watch to understand how an integrated system of tools for protein expression, affinity purification, and quality control testing can help support efficient and cost-effective virus-like particle production on a commercial scale.
Rapid Vaccine Manufacturing for Clinical Trials—Insights from the Malaria Field
Watch to learn how the C-tag affinity tag system is applied as a standard purification process for candidate malaria vaccines to support efficient translation into clinical trials.
Advancing Vaccine Development with Novel Chromatography Solutions and State of the Art Quality Testing
Watch to discover how novel chromatography solutions and analytical testing can help improve the downstream processes of different vaccine modalities such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).
Accelerating Vaccine Development and Large-Scale Manufacturing with Advanced Purification Tools
Learn how novel purification solutions can help improve the downstream process of different vaccine modalities such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).
For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.